SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about board meeting

24 May 2021 Evaluate
Jenburkt Pharmaceuticals has informed that with reference to the Regulation 29(1) and 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 02th June, 2021, at the Registered Office of the Company, to take on record the audited financial results for the quarter and financial year ended on 31st March 2021 and to consider recommendation of Dividend, if any. The Board will also consider a proposal to acquire a land in the state of Gujarat, to set up a modern pharmaceutical formulations manufacturing unit and authorize Director to take necessary steps in respect of the same; and to consider a proposal to begin on pilot scale to sell certain Healthcare products via digital marketing. With reference to letter no. JPL/CS/1690/2021 dated 31st March, 2020, submitted with the Exchange, on the same day, the notional trading window is closed from 1st April, 2021 up to 48 hours after the completion of Board Meeting scheduled on 2nd June, 2021.

The above information is a part of company’s filings submitted to BSE.



Jenburkt Pharma Share Price

1114.65 13.35 (1.21%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: